Literature DB >> 1549776

Human growth hormone and extracellular domain of its receptor: crystal structure of the complex.

A M de Vos1, M Ultsch, A A Kossiakoff.   

Abstract

Binding of human growth hormone (hGH) to its receptor is required for regulation of normal human growth and development. Examination of the 2.8 angstrom crystal structure of the complex between the hormone and the extracellular domain of its receptor (hGHbp) showed that the complex consists of one molecule of growth hormone per two molecules of receptor. The hormone is a four-helix bundle with an unusual topology. The binding protein contains two distinct domains, similar in some respects to immunoglobulin domains. The relative orientation of these domains differs from that found between constant and variable domains in immunoglobulin Fab fragments. Both hGHbp domains contribute residues that participate in hGH binding. In the complex both receptors donate essentially the same residues to interact with the hormone, even though the two binding sites on hGH have no structural similarity. Generally, the hormone-receptor interfaces match those identified by previous mutational analyses. In addition to the hormone-receptor interfaces, there is also a substantial contact surface between the carboxyl-terminal domains of the receptors. The relative extents of the contact areas support a sequential mechanism for dimerization that may be crucial for signal transduction.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1549776     DOI: 10.1126/science.1549776

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  370 in total

1.  Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.

Authors:  R M Arduini; K L Strauch; L A Runkel; M M Carlson; X Hronowski; S F Foley; C N Young; W Cheng; P S Hochman; D P Baker
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

2.  Activation of erythropoietin receptor in the absence of hormone by a peptide that binds to a domain different from the hormone binding site.

Authors:  T Naranda; K Wong; R I Kaufman; A Goldstein; L Olsson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-06-22       Impact factor: 11.205

Review 3.  Receptor recognition by gp130 cytokines.

Authors:  J Bravo; J K Heath
Journal:  EMBO J       Date:  2000-06-01       Impact factor: 11.598

4.  Structural interactions of fibroblast growth factor receptor with its ligands.

Authors:  D J Stauber; A D DiGabriele; W A Hendrickson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-01-04       Impact factor: 11.205

5.  The signal transducer gp130: solution structure of the carboxy-terminal domain of the cytokine receptor homology region.

Authors:  T Kernebeck; S Pflanz; G Müller-Newen; G Kurapkat; R M Scheek; K Dijkstra; P C Heinrich; A Wollmer; S Grzesiek; J Grötzinger
Journal:  Protein Sci       Date:  1999-01       Impact factor: 6.725

Review 6.  Recombinant analogues of prolactin, growth hormone, and placental lactogen: correlations between physical structure, binding characteristics, and activity.

Authors:  A Gertler
Journal:  J Mammary Gland Biol Neoplasia       Date:  1997-01       Impact factor: 2.673

7.  Rapid mapping of protein functional epitopes by combinatorial alanine scanning.

Authors:  G A Weiss; C K Watanabe; A Zhong; A Goddard; S S Sidhu
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-01       Impact factor: 11.205

Review 8.  Growth hormone: new ideas, recurring themes.

Authors:  E O Reiter
Journal:  Endocrine       Date:  2001-06       Impact factor: 3.633

9.  Recruitment of the transcriptional machinery through GAL11P: structure and interactions of the GAL4 dimerization domain.

Authors:  P Hidalgo; A Z Ansari; P Schmidt; B Hare; N Simkovich; S Farrell; E J Shin; M Ptashne; G Wagner
Journal:  Genes Dev       Date:  2001-04-15       Impact factor: 11.361

10.  Reflections on growth hormone.

Authors:  R Deghenghi
Journal:  J Endocrinol Invest       Date:  2000 Jul-Aug       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.